Published in BMC Biol on June 07, 2011
Revisiting lab-on-a-chip technology for drug discovery. Nat Rev Drug Discov (2012) 1.91
A high-throughput screen for Wnt/β-catenin signaling pathway modulators in human iPSC-derived neural progenitors. J Biomol Screen (2012) 1.03
How multi-organ microdevices can help foster drug development. Adv Drug Deliv Rev (2014) 1.00
Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells. Acta Pharmacol Sin (2013) 0.89
Integration of Molecular, Cellular and Translational Researches in BioImpacts. Bioimpacts (2011) 0.81
In-silico models of stem cell and developmental systems. Theor Biol Med Model (2014) 0.81
iPSC technology--Powerful hand for disease modeling and therapeutic screen. BMB Rep (2015) 0.76
Overview of micro- and nano-technology tools for stem cell applications: micropatterned and microelectronic devices. Sensors (Basel) (2012) 0.75
Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases. Annu Rev Pharmacol Toxicol (2015) 0.75
Phenotypic assays for β-amyloid in mouse embryonic stem cell-derived neurons. Chem Biol (2013) 0.75
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Direct conversion of fibroblasts to functional neurons by defined factors. Nature (2010) 18.76
Disease-specific induced pluripotent stem cells. Cell (2008) 16.95
In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature (2008) 16.21
Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell (2010) 15.58
Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science (2008) 14.26
Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell (2010) 14.18
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature (2011) 13.94
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol (2009) 13.16
Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell (2009) 12.96
Directed differentiation of embryonic stem cells into motor neurons. Cell (2002) 9.76
Somatic coding mutations in human induced pluripotent stem cells. Nature (2011) 9.50
Copy number variation and selection during reprogramming to pluripotency. Nature (2011) 8.24
Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell (2011) 8.21
A paracrine requirement for hedgehog signalling in cancer. Nature (2008) 8.16
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci (2007) 7.77
Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature (2009) 7.04
Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell (2011) 6.82
Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell (2011) 6.71
Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture. Science (2010) 6.67
Tissue repair and stem cell renewal in carcinogenesis. Nature (2004) 6.28
Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol (2008) 6.19
Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci (2007) 6.08
Modelling the long QT syndrome with induced pluripotent stem cells. Nature (2011) 5.68
Targeting the Hedgehog pathway in cancer. Nat Rev Drug Discov (2006) 5.30
A functionally characterized test set of human induced pluripotent stem cells. Nat Biotechnol (2011) 4.95
Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat Cell Biol (2011) 4.64
A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell (2009) 4.64
Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature (2010) 4.38
Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell (2008) 3.97
Small-molecule modulators of Hedgehog signaling: identification and characterization of Smoothened agonists and antagonists. J Biol (2002) 3.85
LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell (2011) 3.78
Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature (2011) 3.56
Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell (2009) 3.42
A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell (2010) 3.41
The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol (2007) 3.32
A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat Chem Biol (2009) 3.15
Combinatorial development of biomaterials for clonal growth of human pluripotent stem cells. Nat Mater (2010) 3.11
Geron trial resumes, but standards for stem cell trials remain elusive. Nat Biotechnol (2010) 2.81
Directing astroglia from the cerebral cortex into subtype specific functional neurons. PLoS Biol (2010) 2.60
Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science (2009) 2.60
Stem cells: The dark side of induced pluripotency. Nature (2011) 2.49
Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions. Proc Natl Acad Sci U S A (2003) 2.25
Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res (2009) 2.13
Derivation of neural crest cells from human pluripotent stem cells. Nat Protoc (2010) 2.05
Efficient derivation of functional floor plate tissue from human embryonic stem cells. Cell Stem Cell (2010) 2.02
Clinical experience with Hedgehog pathway inhibitors. J Clin Oncol (2010) 1.93
Engineering myocardial tissue. Circ Res (2005) 1.75
Neural transplantation for the treatment of Parkinson's disease. Lancet Neurol (2003) 1.64
Stem cells and drug discovery: the beginning of a new era? Cell (2008) 1.61
Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Trends Pharmacol Sci (2009) 1.59
Biomimetic platforms for human stem cell research. Cell Stem Cell (2011) 1.58
Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases. Hum Mol Genet (2010) 1.54
The hedgehog pathway and neurological disorders. Annu Rev Neurosci (2006) 1.51
Functional diversity of ESC-derived motor neuron subtypes revealed through intraspinal transplantation. Cell Stem Cell (2010) 1.42
Human stem cells and drug screening: opportunities and challenges. Nat Rev Drug Discov (2010) 1.24
High-throughput analysis of signals regulating stem cell fate and function. Curr Opin Chem Biol (2007) 1.15
Islet transplantation: lessons learned since the Edmonton breakthrough. Transplant Proc (2010) 0.89
Transplantation directs oocyte maturation from embryonic stem cells and provides a therapeutic strategy for female infertility. Hum Mol Genet (2009) 1.23
Intact fetal ovarian cord formation promotes mouse oocyte survival and development. BMC Dev Biol (2010) 0.85
Imaging-based chemical screening reveals activity-dependent neural differentiation of pluripotent stem cells. Elife (2013) 0.78